Prelude Therapeutics (PRLD) Cash & Equivalents Growth (3y) (2022 - 2026)
Prelude Therapeutics (PRLD) Cash & Equivalents Growth (3y) (2022 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash & Equiv. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
24.73% |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
-40.88% |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
-28.55% |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
21.66% |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
-16.07% |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
- |
| 10 |
Prelude Therapeutics |
314.40 Mn |
169.80 Mn |
- |
56.21% |
| Date | Value |
|---|
| Mar 31, 2026 |
56.21% |
| Dec 31, 2025 |
0.58% |
| Sep 30, 2025 |
-3.26% |
| Jun 30, 2025 |
12.18% |
| Mar 31, 2025 |
-7.33% |
| Dec 31, 2024 |
-22.78% |
| Sep 30, 2024 |
-37.25% |
| Jun 30, 2024 |
-54.71% |
| Mar 31, 2024 |
-57.05% |
| Dec 31, 2023 |
-48.78% |
| Sep 30, 2023 |
-56.04% |
| Dec 31, 2022 |
22.43% |
